Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Malle – page 36

1 784 clinical trials in Malle, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Malle at a glance
1 784
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 784 trials in Malle

Open in trial search

Comparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH

Study on Recurrent Colorectal Liver Metastases: Evaluating Calcium Folinate, Fluorouracil, Capecitabine, Oxaliplatin, and Irinotecan in a Drug Combination for Eligible Patients

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Amsterdam UMC Stichting

Hypothyroidism

Recruiting

Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

Study on Botulinum Toxin Type A for Treating Spastic Equinovarus in First-Time Stroke Patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:UZ Leuven

Study Comparing Ulipristal Acetate and Surgery for Women with Symptomatic Uterine Fibroids

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Ulipristal Acetate
  • Sponsor:Amsterdam UMC Stichting

Endometrial cancer+13

Recruiting

Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ifinatamab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Caspofungin
  • Sponsor:Basilea Pharmaceutica International AG Allschwil

Myelofibrosis

Recruiting

Study of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nuvisertib
  • Sponsor:Sumitomo Pharma America Inc.

Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Heidelberg University

Neoplasm malignant+1

Recruiting

Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:68GA-NOTA-abscint-HER2
  • Sponsor:Abscint

Study on Teicoplanin for Preventing Infections in Children with Acute Myeloid Leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Teicoplanin
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Malle

What the registry says about research in the country

01 Neurology Research

Innovative research focusing on post-stroke rehabilitation and spasticity management. The studies aim to evaluate advanced therapeutic approaches for improving mobility in stroke survivors.

  • Spasticity Treatment
  • Neuromuscular Rehabilitation
  • Lower Limb Function

Current investigations explore the neurological effects of BTX A treatment and dry needling techniques, specifically examining their impact on lower limb spasticity at the spinal level.

02 Stroke Recovery Studies

Dedicated research examining innovative approaches to post-stroke complications, with a particular focus on muscle tone management and functional recovery.

  • Movement Disorders
  • Muscle Tone Management
  • Rehabilitation Techniques

The research aims to advance our understanding of therapeutic interventions for improving quality of life in stroke survivors.

03 Physical Medicine

Studies focusing on rehabilitation medicine and innovative treatment approaches for managing post-stroke muscle complications.

  • Physical Therapy Interventions
  • Neuromuscular Treatments
  • Functional Recovery

Current research explores the effectiveness of combined therapeutic approaches in managing spasticity and improving patient outcomes.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.